Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Astellas Pharma Inc. (ALPMY) had Weighted-Average Shares Outstanding (Diluted) of 1.79B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$4.04B |
|
$893.52M |
|
$773.02M |
|
$3.26B |
|
$2.88B |
|
$1.16B |
|
$12.66M |
|
$1.18B |
|
$1.18B |
|
$893.04M |
|
$893.04M |
|
$893.04M |
|
$893.04M |
|
$1.16B |
|
$1.48B |
|
1.79B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.79B |
$0.50 |
|
$0.50 |
|
| Balance Sheet Financials | |
$9.36B |
|
$2.29B |
|
$13.90B |
|
$23.26B |
|
$7.78B |
|
$2.02B |
|
$3.23B |
|
$11.01B |
|
$12.25B |
|
$2.97B |
|
$12.25B |
|
1.79B |
|
| Cash Flow Statement Financials | |
$544.80M |
|
$-436.23M |
|
$-333.57M |
|
$1.77B |
|
$1.54B |
|
$-232.51M |
|
-- |
|
$-440.17M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.20 |
|
-- |
|
-- |
|
0.14 |
|
0.32 |
|
80.86% |
|
28.79% |
|
28.79% |
|
-- |
|
29.10% |
|
22.13% |
|
$465.32M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.36 |
|
0.76 |
|
118.63 |
|
7.29% |
|
30.08% |
|
3.84% |
|
6.26% |
|
$6.83 |
|
$0.26 |
|
$0.30 |
|